Effect of c-Met inhibitor SU11274 on human colon cancer cell growth / 中华医学杂志(英文版)
Chinese Medical Journal
;
(24): 2705-2709, 2013.
Article
in English
| WPRIM
| ID: wpr-322126
ABSTRACT
<p><b>BACKGROUND</b>Colon cancer is one of the major malignancies worldwide and it still remains resistant to much of the currently available chemotherapy. Downregulation of HGF/c-Met signaling pathway is an emerging therapy for cancer treatment.</p><p><b>METHODS</b>In this study, the inhibitory effects of c-Met phosphorylation were observed with SU11274 on different colon cancer cell lines in vitro.</p><p><b>RESULTS</b>The results revealed the significant inhibitory effects of SU11274 on cell proliferation and cell survival, in a time and dose-dependent manner. Furthermore, the inhibitory effects of SU11274 on different subgroups of colon cancer cells via the HGF/c-Met signaling pathway were implicated in this study.</p><p><b>CONCLUSION</b>The results suggested the possible selective therapeutic effects of c-Met inhibitor on colon cancer.</p>
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pathology
/
Pharmacology
/
Physiology
/
Piperazines
/
Sulfonamides
/
Signal Transduction
/
Cell Cycle
/
Hepatocyte Growth Factor
/
Colonic Neoplasms
/
Proto-Oncogene Proteins c-met
Limits:
Humans
Language:
English
Journal:
Chinese Medical Journal
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS